Clinical trial

Primary Glaucoma Treatment Trial in Kenya and South Africa - SLT vs. Medication

NCT02774811

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Prostaglandin analogue Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Selective laser trabeculoplasy Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention laser Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Primary Glaucoma Treatment Trial in Kenya and South Africa - SLT vs. Medication

Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2014-02-01

PhaseNA

Conditions

Glaucomaverified · MONDO: glaucoma

Interventions

Prostaglandin analogueDRUG

Selective laser trabeculoplasyPROCEDURE

laserDEVICE

Sponsors & collaborators

University College, Londonlead sponsor

University of KwaZulucollaborator

Kisii Eye Hospital Kisii Kenyacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02774811 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.